Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank67
3Y CAGR+14.4%
5Y CAGR+54.0%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+14.4%/yr
Annual compound
5Y CAGR
+54.0%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
8.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$377.38M-28.3%
2024$526.32M+12.2%
2023$469.19M+86.1%
2022$252.06M-17.6%
2021$305.83M+602.6%
2020$43.53M+138.7%
2019$18.24M-